Induced Pluripotent Stem Cell (iPSC) Global Market Report 2023

Feb 2023| TBR1484D| TBRC (Publisher)

Sample Report

Report Highlights

Including: 1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells
2) By Application: Academic Research; Drug Development And Discovery; Toxicity Screening; Regenerative Medicine
3) By End-User: Hospitals; Research Laboratories
Covering: Thermo Fisher Scientific Inc.; FUJIFILM Holdings Corporation (Cellular Dynamics); Takara Bio Inc.; Astellas Pharma Inc.; Fate Therapeutics

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on induced pluripotent stem cell (ipsc) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for induced pluripotent stem cell (ipsc) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The induced pluripotent stem cell (ipsc) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Synopsis

Report Metrics	Details
Base year considered	2022
Forecast period considered	2022-2032
Units considered	$ Billion
Segments covered	By Derived Cell Type, By Application, By End-User
Industry covered	Healthcare Services
Regions covered	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered	Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Companies studied	Thermo Fisher Scientific Inc. , FUJIFILM Holdings Corporation (Cellular Dynamics) , ORIG3N , Takara Bio Inc. , Astellas Pharma Inc. , Fate Therapeutics , ViaCyte , StemCells , Japan Tissue Engineering Co. Ltd. , Fate Therapeutics , Ncardia , Axol Bioscience , VIACYTE INC. , REPROCELL , Lonza , BRISTOL-MYERS SQUIBB (IPIERIAN) , ABM (APPLIED BIOLOGICAL MATERIALS INC.) , ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC. , ADDGENE , AXOL BIOSCIENCEE , ALSTEM LLC , APPLIED STEMCELL INC. , ATCC , AXIOGENESIS AG , BIO-TECHNE , BLUEROCK THERAPEUTICS , GENTARGET INC. , ID PHARMA CO. LTD. , INVIVOGEN

Scope

Markets Covered:

By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Other Derived Cells
By Application: Academic Research; Drug Development And Discovery; Toxicity Screening; Regenerative Medicine
By End-User: Hospitals; Research Laboratories

Companies Mentioned: Thermo Fisher Scientific Inc.; FUJIFILM Holdings Corporation (Cellular Dynamics); Takara Bio Inc.; Astellas Pharma Inc.; Fate Therapeutics

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6 : Global Induced Pluripotent Stem Cell (iPSC) Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7 : Global Induced Pluripotent Stem Cell (iPSC) Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8 : Asia-Pacific, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9 : Asia-Pacific, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10 : China, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11 : China, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12 : India, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13 : India, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14 : Japan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15 : Japan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16 : Australia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17 : Australia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18 : Indonesia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19 : Indonesia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20 : South Korea, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21 : South Korea, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22 : Western Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23 : Western Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24 : UK, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25 : UK, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26 : Germany, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27 : Germany, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 28 : France, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 29 : France, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 30 : Eastern Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 31 : Eastern Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 32 : Russia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 33 : Russia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 34 : North America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 35 : North America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 36 : USA, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 37 : USA, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 38 : South America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 39 : South America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 40 : Brazil, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 41 : Brazil, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 42 : Middle East, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 43 : Middle East, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 44 : Africa, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 45 : Africa, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46 : Thermo Fisher Scientific Inc. Financial Performance
Table 47 : FUJIFILM Holdings Corporation (Cellular Dynamics) Financial Performance
Table 48 : Takara Bio Inc. Financial Performance
Table 49 : Astellas Pharma Inc. Financial Performance
Table 50 : Fate Therapeutics Financial Performance

Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5 : Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6 : Global Induced Pluripotent Stem Cell (iPSC) Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7 : Global Induced Pluripotent Stem Cell (iPSC) Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8 : Asia-Pacific, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9 : Asia-Pacific, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10 : China, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11 : China, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12 : India, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13 : India, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14 : Japan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15 : Japan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16 : Australia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17 : Australia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18 : Indonesia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19 : Indonesia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20 : South Korea, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21 : South Korea, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22 : Western Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23 : Western Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24 : UK, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25 : UK, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26 : Germany, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27 : Germany, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 28 : France, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 29 : France, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 30 : Eastern Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 31 : Eastern Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 32 : Russia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 33 : Russia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 34 : North America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 35 : North America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 36 : USA, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 37 : USA, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 38 : South America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 39 : South America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 40 : Brazil, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 41 : Brazil, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 42 : Middle East, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 43 : Middle East, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 44 : Africa, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 45 : Africa, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 46 : Thermo Fisher Scientific Inc. Financial Performance
Figure 47 : FUJIFILM Holdings Corporation (Cellular Dynamics) Financial Performance
Figure 48 : Takara Bio Inc. Financial Performance
Figure 49 : Astellas Pharma Inc. Financial Performance
Figure 50 : Fate Therapeutics Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2031

Published Date - Nov 2022
Report Code - TBR1484C

Including: 1) By Derived Cell Type: Blood Cells; Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells
2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Cell & Gene Therapy
3) By End-User: Hospitals; Research Laboratories
Covering: FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc); Thermo Fisher Scientific, Inc; Takara Bio, Inc; Lonza Group AG; Astellas Pharma Inc

Induced Pluripotent Stem Cell ...

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022

Published Date - Feb 2022
Report Code - TBR1484B

Including: 1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Others
2) By Application: Academic Research; Drug Development And Discovery; Toxicity Screening; Regenerative Medicine
3) By End-User: Hospitals; Research Laboratories
Covering: Thermo Fisher Scientific Inc.; FUJIFILM Holdings Corporation (Cellular Dynamics); Takara Bio Inc.; Astellas Pharma Inc.

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022 from ...

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change

Published Date - Aug 2021
Report Code - TBR1484A

Including: 1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic; Others
2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Gene & Cell Therapy
3) By End-User: Hospitals; Research Laboratories
Covering: Fujifilm Holding Corporation; Thermo Fisher Scientific Inc.; Takara Bio Inc.; ViaCyte; Fate Therapeutics

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2030: COVID-19 ...